Shining the Light on the Third-Party Litigation Funding

December 5, 2017 10:30am

Ashley A. Garry
Counsel – Litigation and Legal Compliance
Eli Lilly and Company (Indianapolis IN)

Tarifa B. Laddon
Faegre Baker Daniels LLP (Los Angeles, CA)

Kim M. Schmid
Firm Vice Chair And Executive Managing Partner
Bowman and Brooke LLP

Michelle W. Cohen
Patterson Belknap Webb and Tyler LLP (New York, NY)

  • Understanding the rise of third-party litigation funding
    • Latest developments and how this phenomenon is changing the balance of power in litigation
    • How is this fueling drug and medical device products liability litigation?
  •  How common is this and how are cases being funded?
  • Best practices for maintaining control when the third-party funder is driving the litigation
  • Considerations for resolution and settlement in this increasingly complicated arena